Wenge Shi

Wenge Shi has a strong background in clinical science and biomarkers, with experience at various companies in the biopharmaceutical industry. Wenge has held roles such as Director of Clinical Science and Biomarkers at Ambrx, Associate Scientific Director at Navigate Biopharm Services, and Associate Director at Genoptix Medical Laboratory. Shi's expertise includes developing and validating Next Generation Sequencing assays, as well as contributing to projects related to cancer diagnosis, prognosis, and monitoring.

Wenge Shi holds a Ph.D. in Human Oncology from the University of Wisconsin-Madison and a B.S. in Genetics and Genetic Engineering from Fudan University. In 2014, Shi obtained the MB(ASCP) certification from the American Society for Clinical Pathology (ASCP).